Intus Bio-Led Consortium Receives $2.7M NIH/NCI Fast-Track Award for Bacteria-Based Early-Onset Colorectal Cancer Test

Bacteria-Based Early-Onset Colorectal Cancer TestPositive

AI Analysis

Summary

Intus Bio-led consortium received a $2.7M NIH/NCI Fast-Track Award to develop a non-invasive bacterial microbiome-based screening test for early-onset colorectal cancer with researchers from four major institutions.

Importance:4/10

Sentiment:

0.60

NIH fundingNCIcolorectal cancermicrobiomediagnosticnon-invasiveearly-onset

Read the original article

Published by PR Newswire Biotech on September 11, 2026 12:30 PM

Read Original